Evidence based therapy for primary liver cancer
10.3760/cma.j.issn.1007-8118.2011.12.001
- VernacularTitle:原发性肝癌的循证治疗策略
- Author:
Yitao DING
;
Decai YU
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Evidencebased medicine;
Therapy
- From:
Chinese Journal of Hepatobiliary Surgery
2011;17(12):953-958
- CountryChina
- Language:Chinese
-
Abstract:
Progress in multi-disciplinary therapy for primary liver cancer (PLC) increases the 5-year survival rate from 2.6％ to 20.6％.However,the overall survival rate failed to increase significantly in the past twenty years because of lack of standardization in treatment of PLC.It is important to establish clinical guidelines which are based on randomized controlled trials,meta analysis,or systematic reviews.This review summarizes the pertinent clinical trials on PLC therapies published before October 2010.The articles were selected by a comprehensive literature search using the terms ‘liver neoplasms',‘ hepatectomy',‘ liver transplantation',‘ transarterial chemoembolization',‘ radiofrequency ablation',‘ percutaneous ethanol injection',‘ radiotherapy',‘ biological therapy',‘ chemotherapy',or ‘ Chinese herbs’.
